Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cyclophosphamide 1499 Cisplatin 1436 Paclitaxel 1342 Radiotherapy 1310 Carboplatin 1267 Gemcitabine 1226 Docetaxel 1135 Bevacizumab 1071 Fluorouracil 907 Doxorubicin 805 Dexamethasone 755 Rituximab 745 Capecitabine 736 Oxaliplatin 710 pembrolizumab 700 Etoposide 679 Irinotecan 641 Filgrastim 624 Nivolumab 588 Cytarabine 587 Leucovorin 583 Vincristine 517 Cetuximab 479 Prednisone 478 Bortezomib 474 Trastuzumab 468 Erlotinib Hydrochloride 467 Surveys and Questionnaires 460 Methotrexate 444 Lenalidomide 437

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × ASTX029 × Clear all

NCT03520075 2025-07-03

Study of ASTX029 in Subjects With Advanced Solid Tumors

Taiho Oncology, Inc.

Phase 1/2 Completed

192 enrolled 56 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡